Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate

被引:9
作者
Niu, Jingya [1 ,2 ,3 ]
Zhang, Xiaoyun [1 ,2 ]
Li, Mian [1 ,2 ]
Wu, Shujing [1 ,2 ]
Zheng, Ruizhi [1 ,2 ]
Chen, Li [4 ]
Huo, Yanan [5 ]
Xu, Min [1 ,2 ]
Wang, Tiange [1 ]
Zhao, Zhiyun [1 ,2 ]
Wang, Shuangyuan [1 ,2 ]
Lin, Hong [1 ,2 ]
Qin, Guijun [6 ]
Yan, Li [7 ]
Wan, Qin [8 ]
Chen, Lulu [9 ]
Shi, Lixin [10 ]
Hu, Ruying [11 ]
Tang, Xulei [12 ]
Su, Qing [13 ]
Yu, Xuefeng [14 ]
Qin, Yingfen [15 ]
Chen, Gang [16 ]
Gao, Zhengnan [17 ]
Wang, Guixia [18 ]
Shen, Feixia [19 ]
Luo, Zuojie [15 ]
Chen, Yuhong [1 ,2 ]
Zhang, Yinfei [20 ]
Liu, Chao [21 ]
Wang, Youmin [22 ]
Wu, Shengli [23 ]
Yang, Tao [24 ]
Li, Qiang [25 ]
Mu, Yiming [26 ]
Zhao, Jiajun [27 ]
Bi, Yufang [1 ,2 ]
Ning, Guang [1 ,2 ]
Wang, Weiqing [1 ,2 ]
Lu, Jieli [1 ,2 ]
Xu, Yu [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp,Sch Med,Metab Dis Natl Hlth Commiss P, Shanghai Key Lab Endocrine Tumor,Key Lab Endocrin, State Key Lab Med Genom,Shanghai Natl Clin Res Ct, Shanghai, Peoples R China
[3] Shanghai Univ Med & Hlth Sci, Jiading Dist Cent Hosp Affiliated, Shanghai, Peoples R China
[4] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[5] Jiangxi Peoples Hosp, Nanchang, Jiangxi, Peoples R China
[6] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[7] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[8] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
[9] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[10] Guiyang Med Coll, Affiliated Hosp, Guiyang, Peoples R China
[11] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China
[12] Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China
[13] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China
[14] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[15] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China
[16] Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Peoples R China
[17] Dalian Municipal Cent Hosp, Dalian, Peoples R China
[18] First Hosp Jilin Univ, Changchun, Peoples R China
[19] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[20] Cent Hosp Shanghai Jiading Dist, Shanghai, Peoples R China
[21] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Peoples R China
[22] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China
[23] Karamay Municipal Peoples Hosp, Xinjiang, Peoples R China
[24] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China
[25] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China
[26] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[27] Shandong Univ, Shandong Prov Hosp, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
Albuminuria; Chronic kidney disease progression; Diabetic kidney disease; Glomerular filtration rate; Major cardiovascular event; Mortality; CHRONIC KIDNEY-DISEASE; ALL-CAUSE; MORTALITY; ADULTS; CHINA; ASSOCIATION; DYSFUNCTION; PREVALENCE; REGRESSION; ABSENCE;
D O I
10.1016/j.diabet.2023.101420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: We aimed to examine risks of major cardiovascular events (MACEs), renal outcomes, and all-cause mortality in type 2 diabetes mellitus (T2DM) patients with different diabetic kidney disease (DKD) subtypes.Methods: A total of 36,509 participants with T2DM recruited from 20 community sites across mainland China were followed up during 2011-2016. DKD subtypes were categorized based on albuminuria (urinary albumin-to-creatinine ratio, UACR >= 30 mg/g) and reduced estimated glomerular filtration rate (eGFR < 60 ml/min/1.73 m2) as Alb-/eGFR-, Alb'/eGFR-, Alb-/eGFR', and Alb'/eGFR'. Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs) of developing clinical outcomes in DKD subtypes.Results: More than half (53.5%) of participants with diabetes and reduced eGFR had normal UACR levels (Alb-/ eGFR'), termed as non-albuminuria DKD. These patients had a modest increase in the risks of MACEs (hazard ratio, HR 1.42 [95% CI 1.08;1.88]) and mortality (HR 1.42 [1.04;1.92]) compared with patients without DKD, whereas CKD progression was not significantly increased (HR 0.97 [0.60;1.57]). Participants with albuminuria (Alb'/eGFR- or Alb'/eGFR') had higher risks of clinical outcomes. Subgroup analysis revealed that the associations between non-albuminuria DKD and risks of MACEs and mortality were more evident in those aged <65 years.Conclusion: Non-albuminuria DKD accounts for more than half of DKD cases with low eGFR in Chinese diabe-tes patients. Diabetes patients with albuminuria are at higher risks of developing clinical outcomes and war-rant early intervention, as well as patients with non-albuminuria DKD with age < 65 years.(c) 2023 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:9
相关论文
共 34 条
[21]   Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes [J].
Porrini, Esteban ;
Ruggenenti, Piero ;
Mogensen, Carl Erik ;
Barlovic, Drazenka Pongrac ;
Praga, Manuel ;
Cruzado, Josep M. ;
Hojs, Radovan ;
Abbate, Manuela ;
de Vries, Aiko P. J. .
LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (05) :382-391
[22]   Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study [J].
Pugliese, Giuseppe ;
Solini, Anna ;
Bonora, Enzo ;
Orsi, Emanuela ;
Zerbini, Gianpaolo ;
Fondelli, Cecilia ;
Gruden, Gabriella ;
Cavalot, Franco ;
Lamacchia, Olga ;
Trevisan, Roberto ;
Vedovato, Monica ;
Penno, Giuseppe .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[23]   Risk factors for renal dysfunction in type 2 diabetes - UK prospective diabetes study 74 [J].
Retnakaran, Ravi ;
Cull, Carole A. ;
Thorne, Kerensa I. ;
Adler, Amanda I. ;
Holman, Rury R. .
DIABETES, 2006, 55 (06) :1832-1839
[24]   Non-Proteinuric Diabetic Nephropathy [J].
Robles, Nicolas Roberto ;
Villa, Juan ;
Gallego, Roman Hernandez .
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (09) :1761-1773
[25]   Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis [J].
Shi, Shaomin ;
Ni, Lihua ;
Gao, Ling ;
Wu, Xiaoyan .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[26]  
Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.2337/dc14-1296, 10.1053/j.ajkd.2014.08.001]
[27]   Prevalence and Risk Factors for CKD: A Comparison Between the Adult Populations in China and the United States [J].
Wang, Fang ;
He, Kevin ;
Wang, Jinwei ;
Zhao, Ming-Hui ;
Li, Yi ;
Zhang, Luxia ;
Saran, Rajiv ;
Bragg-Gresham, Jennifer L. .
KIDNEY INTERNATIONAL REPORTS, 2018, 3 (05) :1135-1143
[28]   Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study [J].
Wang, Tiange ;
Lu, Jieli ;
Shi, Lixin ;
Chen, Gang ;
Xu, Min ;
Xu, Yu ;
Su, Qing ;
Mu, Yiming ;
Chen, Lulu ;
Hu, Ruying ;
Tang, Xulei ;
Yu, Xuefeng ;
Li, Mian ;
Zhao, Zhiyun ;
Chen, Yuhong ;
Yan, Li ;
Qin, Guijun ;
Wan, Qin ;
Dai, Meng ;
Zhang, Di ;
Gao, Zhengnan ;
Wang, Guixia ;
Shen, Feixia ;
Luo, Zuojie ;
Qin, Yingfen ;
Chen, Li ;
Huo, Yanan ;
Li, Qiang ;
Ye, Zhen ;
Zhang, Yinfei ;
Liu, Chao ;
Wang, Youmin ;
Wu, Shengli ;
Yang, Tao ;
Deng, Huacong ;
Zhao, Jiajun ;
Lai, Shenghan ;
Bi, Yufang ;
DeFronzo, Ralph A. ;
Wang, Weiqing ;
Ning, Guang .
LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02) :115-124
[29]   Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency [J].
Yamamoto, Yui ;
Hanai, Ko ;
Mori, Tomomi ;
Yokoyama, Yoichi ;
Yoshida, Naoshi ;
Murata, Hidekazu ;
Shinozaki, Tomohiro ;
Babazono, Tetsuya .
DIABETOLOGIA, 2022, 65 (01) :234-245
[30]   Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25) [J].
Yokoyama, H. ;
Araki, S. ;
Haneda, M. ;
Matsushima, M. ;
Kawai, K. ;
Hirao, K. ;
Oishi, M. ;
Sugimoto, K. ;
Sone, H. ;
Maegawa, H. ;
Kashiwagi, A. .
DIABETOLOGIA, 2012, 55 (07) :1911-1918